Global POC Haematology Diagnostics Market 2024-2028
The POC haematology diagnostics market is forecasted to grow by USD 7.15 bn during 2023-2028, accelerating at a CAGR of 10.33% during the forecast period. The report on the POC haematology diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of blood disorders and infectious diseases, increasing growth in POC hematology diagnostics product launches, and the paradigm shift from benchtop to portable hematology diagnostic systems.
Technavio's POC haematology diagnostics market is segmented as below:
By End-user
Hospitals and clinics
Homecare settings
Clinical diagnostic laboratories
By Product
Consumables
Systems
By Geography
North America
Europe
Asia
Rest of World (ROW)
This study identifies the increase in online marketing as one of the prime reasons driving the POC haematology diagnostics market growth during the next few years. Also, increase in the number of OEMs and increase in adoption of next-generation hematology diagnostic products will lead to sizable demand in the market.
The report on the POC haematology diagnostics market covers the following areas:
POC haematology diagnostics market sizing
POC haematology diagnostics market forecast
POC haematology diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POC haematology diagnostics market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, Chengdu Seamaty Technology Co. Ltd., Danaher Corp., DIAGON Kft., Diamond Diagnostics Inc., Drucker Diagnostics LLC, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., HORIBA Ltd., Medsource Ozone Biomedicals Pvt. Ltd., Norma Instruments Zrt., Nova Biomedical Corp., PixCell Medical Technologies Ltd., S.D. Sight Diagnostics Ltd., Sekisui Diagnostics LLC, Mindray Bio medical Electronics Co. Ltd., Siemens AG, Sysmex Corp., and Transasia Bio Medicals Ltd.. Also, the POC haematology diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.